EFPIA Newsletter 27 March 2025

Blogs     20 March 2025 Unmet medical need: How patient perspectives drive meaningful innovation (Guest blog) A restrictive definition of unmet need would limit researchers’ capacity to deliver what matters to patients. Read more →

Discover EFPIA President's views on how to create a healthier, more competitive Europe

Watch EFPIA President Lars Fruergaard Jørgensen discuss how we can work together to make Europe the leading destination for research, development, and manufacturing of new diagnostics, treatments, and vaccines.

	EFPIA Conference 2024 - What cure to boost EU competitiveness		IMAGINE a healthier, more competitive Europe: Interview with Lars Fruergaard Jørgensen

Events     03 APR 2025   Unlocking efficiency through reliance: Navigating the EMA post-authorization framework... Virtual event Register now to join this webinar. Learn more →       15 APR 2025   Vaccines & the EU HTA regulation: Why, what and how? Virtual event With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines... Learn more →

	24 APR 2025			IHI online event on childhood cancer research tools Virtual event Join to discover the results of the ITCC-P4 public-private partnership. Learn more →

	13 MAY 2025			International conference on protein stability – The gap between industry and administration... Södertälje Science Park, Sweden The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial... Learn more →

What we are reading How can Europe regain its position as the premier location for scientific research, skills... 26 March 2025  (Quotidiano Sanità) Read more → Have your say on the new strategy for European Life Sciences 26 March 2025  (European Commission) Read more → Health is a strategic investment in human capital, not a cost, argues new report 21 March 2025  (Euractiv) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe